AzTrials
AzTrials

Depressive DisorderNCT05335564

Evaluation of a Website to Improve Depression Literacy in Parents of Adolescents With Depression

A study testing General information about depression in people with Depressive Disorder and Depression in Adolescence, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in parents of adolescents with acute or remitted depressive… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
General information about depression
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteGermany
Study dates
20 Jan 2021to 2 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • The presence of a current or remitted diagnosis of a mild, moderate, or severe major depressive episode according to ICD-10 Criteria: F32.0; F32.1; F32.2, F33.0, F33.1, F33.2) in the participants' children is assessed using a semi-structured clinical interview: the "Kinder-DIPS". The Kinder-DIPS is a well-established German interview for the diagnosis of a wide range of axis I psychiatric disorders in children from ages six to 18.

Who cannot join

  • Insufficient knowledge of German

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Munich

    Munich, Bavaria, 80336

Other trials in Germany

About this study

Official title: Evaluating the Efficacy and the Acceptability of the Website "Ich Bin Alles" to Improve Depression Literacy in Parents of Adolescents With Acute or Remitted Major Depressive Disorder

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in parents of adolescents with acute or remitted depressive disorder. The investigators will examine whether the website improves depression literacy in parents of adolescents aged 12 to 18 years with a history of depression. The investigators will also assess the acceptability of the website among the participants.

Read the detailed description

Few young people with major depressive disorder seek professional treatment in time. Concerns about social stigma, confidentiality, and limited knowledge about mental health conditions, such as depression, or mental health services are some of the main barriers to seek treatment. Increasing parents' knowledge about and attitude towards depression and mental health in childhood and adolescence is important to increase parents' awareness towards their children's mental health and reduce possible prejudices and barriers towards depression and treatment. These aspects might contribute to more parents seeking professional help and treatment for their children at an early point of time in the course of a depressive disorder. To address these issues and contribute to knowledge gain, we developed an evidence-based website "ich bin alles" (https://www.ich-bin-alles.de/) with two separate sub-websites for (1) adolescents and (2) parents to improve depression literacy in these groups.

To improve depression literacy in parents, the website provides general information for parents about depression in childhood and adolescence (e.g., symptoms, causes, course and treatment of depression). Furthermore, the website provides information about strategies for parents on how to support their children if they are affected by depression and on appropriate prevention strategies; i.e., strategies for promoting mental health (e.g., providing a healthy environment, reducing stress, undertaking positive activities, positive parenting), which are meant to serve as an addition to professional treatments of depression or to promote mental health in adolescents.

Target groups of the website are parents of adolescents aged 12 to 18 years with a history of depression, as well as parents of healthy adolescents aged 12 to 18 years. Easy access to information about depression would make early recognition of depression more likely and engage parents to help their children to seek help for depression.

Since the website targets two different groups, the investigators will evaluate the website accordingly:

Target group 1: Parents of adolescents with a major depressive disorder (acute or remitted) Target group 2: Parents of healthy adolescents (without a mental health condition)

The current study will focus on target group 1. A study focusing on target group 2 can be found in a separately registered clinical trial on clinicaltrials.gov.

The primary aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy in parents of adolescents with acute or remitted depressive disorder.

Being tested
General information about depression
Keywords
Knowledge, Mental Health, Depression Literacy, Website, Online, Adolescence, Youth, Parental Behaviour
Medical subject headings
Depressive Disorder, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • General information about depressionOther

    Before starting the intervention, the participants are told that they will be shown parts of a website about depression. The participants are instructed to carefully attend to the website (e.g., to read the text precisely, to hear attentively to the podcasts and to view carefully the videos and images on the website). The time window spent for the reception of each part of the website are fixed.

    The participants will be shown parts of the website regarding general information about depression.

Study groups in NCT05335564
Study groupRoleWhat they receive
General information about depressionExperimentalExposure to general information about depression
Receives: Other: General information about depression

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depression Literacy - Depression in children and adolescents as psychiatric disorder

    This self-designed questionnaire is a self-report inventory to assess knowledge of depression in children and adolescents (frequency and comorbidities, treatment, symptoms, causes and course of depression; 26 items), with higher scores indicating more knowledge of depression as psychiatric disorder. Participants will complete this self-designed questionnaire at pre-test, post-test and follow-up to determine change in knowledge of depression in children and adolescents.

    Measured: Pre-Test, Post-Test (within 2 hours), Follow-Up (Week 4)

Secondary outcomes (2)
  1. Visual Aesthetics of Websites Inventory Short Version (VisAWI-S)

    The short version of the Visual Aesthetics of Websites Inventory (VisAWI-S) is self-report inventory to assess the evaluation of the website's design - especially the perceived visual aesthetics. Participants indicate their response to the four items (e.g., "The layout appears professionally designed") on a seven-point Likert scale (ranging from 1 "do not agree at all" to 7 "do fully agree").

    Measured: Post-Test (within 2 hours)

  2. Overall reception of the website

    The overall reception of the website as measured with a self-designed questionnaire.

    Measured: Post-Test (within 2 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2022
  2. Study start20 Jan 2021
  3. Primary completion2 May 2022
  4. Study completion2 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05335564
Sponsor's protocol ID
20116_1
Status last verified
Jun 2022
First submitted
1 Apr 2022
Last updated
30 Jun 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data in our study contains sensitive participant information, such as sociodemographic information and information on comorbidities. Since participants could possibly be identified by making our raw data publicly available, ethical principles of protecting participant confidentiality would be breached. Aggregated group data can be made available upon request.

Publications

  • Iglhaut L, Primbs R, Kaubisch S, Koppenhofer C, Piechaczek CE, Keim PM, Kloek M, Feldmann L, Schulte-Korne G, Greimel E. Evaluation of a web-based information platform on youth depression and mental health in parents of adolescents with a history of depression. Child Adolesc Psychiatry Ment Health. 2024 Jan 13;18(1):7. doi: 10.1186/s13034-023-00703-x.

    PubMed 38218899

Questions about this trial

What is this clinical trial studying?

A study testing General information about depression in people with Depressive Disorder and Depression in Adolescence, run by Ludwig-Maximilians - University of Munich at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Depression Literacy - Depression in children and adolescents as psychiatric disorder (time frame: Pre-Test, Post-Test (within 2 hours), Follow-Up (Week 4)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05335564, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in